Recent studies have demonstrated that EZ235, a potent inhibitor of the PI3K-AKT-mTOR pathway, effectively downregulates VEGF expression and triggers autophagy in glioblastoma cells [158]. The gene discussed is MTOR; the disease is glioblastoma.